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Summary.-The deformability oferythrocytes, which is afactor ofutmostimportance
both for capillary perfusion and for determining erythrocyte life span, has been
studied in patients with solid tumours and in healthy subjects. Deformability was
significantly decreased in all patients, especially those with anaemia. In this latter
group of patients, carboxyhaemoglobin saturation of blood (COHb), reflecting
erythrocyte haemoglobin breakdown, was also significantly increased, and this
increase was closely correlated with the degree of impaired deformability of the
erythrocytes. In the group of patients without anaemia, where erythrocyte deform-
ability was also impaired, no such correlation was found. In4 patients with Hodgkin's
disease and fever as part of B symptoms, erythrocyte deformability decreased during
fever and returned to normal when fever subsided. In 2 of these patients the adminis-
tration of a prostaglandin-synthesis inhibitor (indomethacin) evoked a deformability,
which was even better than during periods without fever. Since fever in Hodgkin
patients with B symptoms has been attributed to the production of prostaglandins,
these results may suggest a relationship between prostaglandin production and
erythrocyte deformability in patients with malignant tumours. The close correlation
between the degree of decrease in erythrocyte deformability and COHb levels in the
patients with anaemia might indicate a role for prostaglandins in the production of
anaemia of malignancy.
PATIENTS with malignant tumours often
develop anaemia during some period of
their disease. This symptom has been
attributed to chronic blood loss or de-
ficiences in dietary intake, but mostly to
an incompletely compensated haemolysis.
The haemolysis has been ascribed to a
shortening of the life span of circulating
mature erythrocytes but also of young
erythrocytes in the marrow before their
release to the blood stream, i.e. ineffective
erythropoiesis (Cavallin-St'ahl et al., 1976).
The mechanisms behind the premature
cell death are probably many, but the
importance of a hyperphagocytic reticulo-
endothelial system has been stressed by
many investigators (Friedel, 1965; Hyman
& Hlrvey, 1955; Magarey & Baum, 1970).
By means of isotope-labelling methods
for red cells and the measurement of
microsomal haemoxygenase activity res-
ponsible for the enzymatic degradation of
haemoglobin, it has been found that
organs such as spleen, liver and marrow,
with capillaries rich in reticuloendothelial
cells, are the sites of red-cell destruction
(Salky et al., 1967; Schacter et al., 1979).
Erythrophagocytosis has been seen in the
marrow of cancer patients and spleens of
tumour-bearing animals, using morpho-
logical methods (Ponder & Ponder, 1958).
The deformability of the red cell is a
biophysical factor, which determines
whether the red cell can traverse capil-
laries in the microcirculation, often with
a smaller diameter than the cell itself. If
the cell gets stuck in the fine blood vessels,
it causes vascular stasis and may rupture.
Such a mechanism has been claimed to be
of importance for the haemolysis seen inC. E. MERCKE
certain inherited and acquired haemolytic
anaemias (Jandl et al., 1961; LaCelle,
1970; Rieber et al., 1977; Usami et al.,
1975; Weed, 1975). The process, resulting
in cell destruction, has been defined as a
physical one of simple filtration (Jandl
et al., 1961). A decreased deformability of
red cells from patients with solid tumours
has been described earlier in a preliminary
report (Mercke & Cavallin-Stahl, 1978)
and also in patients with acute leukaemia
(Dintenfass, 1977). How this pathophysio-
logical mechanism is related to the
premature red-cell death as registered in
the liver, spleen and marrow in patients
with malignant tumours has not, however,
been reported on before.
Carbon monoxide, bound to haemo-
globin in the blood (COHb) results from
breakdown of haeme, yielding molar con-
centrations of carbon monoxide and
bilirubin. Even if COHb level reflects the
turnover of all haeme sources (i.e. haemo-
globin in circulating erythrocytes and
marrow, haeme-containing enzymes ofthe
liver, and myoglobin) it is a good semi-
quantitative measure of the breakdown
ofhaemoglobin in circulating erythrocytes,
since this pool is so much larger than the
other pools (Engstedt, 1957). Reticulocyte
count reflects the capacity of the marrow
to respond to the demand for new erythro-
cytes. The present study reports on eryth-
rocyte deformability in a fairly large
group of patients with solid tumours,
who are compared to a reference group of
healthy men. Analysis of serum haemo-
globin, COHb and reticulocyte count,
together with erythrocyte deformability,
might help to explain what this factor
means for the development of anaemia in
patients with such diseases.
MATERIAL AND METHODS
Patients.-The material consists of 50
patients (22 M; 28 F; mean age 57 years) with
solid tumours of different kinds, 42 with
carcinomas and 8 with lymphomas. For
pertinent clinical and laboratory data see
Table. Twenty-five patients, Group A, had
anaemia (S-Hb < 115 g/l) and the other half,
Group B, had normal serum haemoglobin
concentrations (> 115 g/l). Nine healthy non-
smoking men (mean age 24) served as control
Group C. All patients considered eligible for
the study had their malignant disease diag-
nosed shortly before the study. Therefore
they had not received prior antitumour
therapy (i.e. surgery, radiotherapy or chemo-
therapy) and no such therapy was being
given at the time ofblood sampling. The only
medications allowed were barbiturates and
analgesics, but these were withdrawn 48 h
before blood sampling. Smokers abstained
from smoking for 36 h before. To be accepted
for the study no patient should have lost or
gained weight during the last month, and
they should all be on a normal diet. They
were considered to be in steady state haemat-
ologically; no patient showed signs of overt
bleeding and no blood transfusions had been
given. Premenopausal women were excluded
from this study, due to known fluctuations
in red-cell deformability during the menstrual
cycle (Mercke & Lundh, 1976). All blood
samples were collected in the morning around
07:30, with the patients fasting for at
least 8 h.
Measurement of erythrocyte deformability.-
Erythrocyte deformability (ED) was deter-
mined by a method slightly modified from
the one described by Miller et al. (1971).
Ten ml of blood were collected in heparin-
TABLE.-Mean values (±s.d.) of serum haemoglobin, impairment of erythrocyte deform-
ability (AP), carboxyhaemoglobin per cent saturation of blood and reticulocyte countfor
cancer patients with anaemia, without anaemia and healthy controls
Serum
haemo-
globin
Group (g/l)
A Anaemia (Hb < 115 g/l) 10-6+0-6
B No anaemia (Hb >115 g/l) 13-5+1-3
C Healthy controls 150+ 1-4
* .1P =impairment of erythrocyte deformability.
AP/min*
(cm H20)
119+ 30
83 + 25
46+10
COHb
(%)
0-69 + 0 34
0-43 + 0-17
0-44+0-11
Retic.
count
x 103/1)
38 + 13
38 + 15
26+ 8
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ized tubes and washed x 3 in 0155M phos-
phate buffer (pH 7 4) with a glucose concen-
tration of 5 mm. The cell suspension was left
to equilibrate with the buffer for 10 min at
370C. The suspension was then centrifuged at
room temperature and the packed erythro-
cytes were diluted with the buffer to a final
haematocrit of5%. The cell suspension to be
filtered was placed in a precalibrated 5ml
disposable plastic syringe monitored on a
constant-infusion syringe pump with a flow
rate of 1-94 ml/min. Polyearbonate sieves
(Nucleopore Corporation, Pleasonton, Cali-
fornia, U.S.A.) with a mean pore diameter of
5 jtm and a pore density of - 3 x O4/cm2
were precut to discs ofabout 15 mm diameter.
The sieve was placed in a specially designed
plexiglass filter holder which was connected
to the plastic syringe and a pressure trans-
ducer. The pressure-time curve was moni-
tored on a Servogor strip chart recorder. The
response of the pressure transducer was
calibrated with a water-column manometer.
Before each test the filter holder was
rinsed with fresh buffer and a control filtra-
tion curve with only buffer was recorded.
When the syringe was filled with the erythro-
cyte suspension it was connected to the filter
holder. Great care was now taken to avoid
the presence of air bubbles, especially inside
the filter housing and in the connecting tubes
close to the pressure transducer. After the
infusion pump was started, erythrocytes in
suspension were pushed against the filter and
a pressure-time curve for the sample was
monitored. All pressure recordings were pro-
cessed in duplicate, always within 2 h of
blood collection. A reference value was ob-
tained from weekly studies during 4 weeks in
9 healthy men. Variation from week to week
within the same individual was below 15%.
Reproducibility was studied in 30 duplicate
analyses from the same material. The co-
efficient of variation for a single analysis was
12%.
Other analyses.-The CO-contents of the
blood samples was measured by gas chromat-
ography as described by Collison et al. (1968)
withthemodification ofLundh etal. (1975a,b).
Reticulocytes were counted by the method
of Bjorkman (1958) and haemoglobin con-
centration was determined by a Coulter
counter.
Calculation of erythrocyte deformability.
Typical tracings of pressure-time curves
obtained from samples of erythrocytes from
P, cm H20
Buffer
5 60 sec
FicG. 1. Typical recordings of pressure-time
curves for cell-free buffer, samples of
erythrocytes from healthy subjects (C),
patients without anaemia (B) and witl
anaemia (A).
the patient group and the reference group
are shown in Fig. 1. The pressure showed
an immediate increase atthe start offiltration
and a gradual increase as the filtration
proceeded. Curves were recorded until the
syringe with the blood suspension was
emptied. After 5 seconds and 65 seconds
respectively, pressure were registered (PO and
Pt) and the two points were connected by a
straight line. This line was almost always
identical to the one that could be fitted by eye
to the slope ofthe whole pressure-time curve.
The change in pressure per min (AP/min) was
calculated from the slope of the straight line.
A high value of AP/min therefore means a
poor deformability of the red cells.
Statistical method.-The data were analysed
by the t test.
RESULTS
The AP/min for Group A (patients with
anaemia) was 119 + 30 cm H20, which
was significantly higher than for Group
B (no anaemia) where the corresponding
value was 83 + 25 (P < 0.005). In the
reference group of healthy men AP/min
was significantly lower than in the patient
group; namely 45 + 8 (P< 0-001). COHb
values were 0-69 + 0 34, 0 43 + 0-17, and
0-44 + 0.11 respectively, with a significant
difference between Group A and the other
groups (P < 0-01) but no difference between
Groups B and C. Reticulocyte counts
were almost the same for all groups;
namely 38 + 13, 38 + 15, and 26 + 8 x 103/1
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FIG. 2.-Erythrocyte deformability (AP), erythrocyte haeme catabolism (COHb), and reticulocyte
count for tumour-bearing patients with (A) and without anaemia (B) and healthy subjects (C)
respectively. Bars indicate + s.d.
(Fig. 2). No relation between AP/min and
COHb could be shown for all subjects, but
if only Group A was analysed, a highly
significant correlation between these two
variables was found (r= 0-72, n= 25
P<0-001; Fig. 3). No significant correla-
tions could be found between serum
haemoglobin levels or reticulocyte counts
on the one hand and the other parameters.
In 4 patients with Hodgkin's disease
and general symptoms (B symptoms) one
from Group A and 3 from Group B, AP
was also recorded during periods of fever
considered to be of noninfectious origin.
There was a meanrise of AP of44% during
these fevers, with a return to prefever
values when the fever subsided spon-
taneously. In 2 patients, 200 mg/day of
indomethacin was given during another
fever, with a prompt effect on fever and
AP. In these patients AP decreased to
levels 34 and 30% below prefever values
respectively (Fig. 4).
DISCUSSION
The deformability of human erythro-
cytes comprises effects of cell shape,
membrane flexibility and fluidity of the
intracellular haemoglobin solution (Jandl
et al., 1961). A decrease in deformability
predisposes red cells to being trapped and
sequestered in the microcirculation, par-
ticularly the spleen andliver, inwhich case
cellular haemoglobin is degraded in situ
and the clinical picture is "haemolysis".
This mechanism ofpremature cell destruc-
tion has been demonstrated for certain
anaemias such as sickle-cell anaemia,
hereditary sphaerocytosis and acquired
auto-immune haemolytic anaemias (Weed
1975; Usami et al., 1975; Jandl et al.,
1961; LaCelle, 1970; Rieber et al., 1977)
but also during the progesterone phase of
the menstrual cycle in healthy women
without anaemia (Mercke & Lundh, 1976).
The same mechanism has also been pro-
posed as a determinant of the release of
maturing red cells (reticulocytes) from the
marrow (Leblond et al., 1971).
The data in the present study show a
significantlylowerythrocyte deformability
in patients with solid tumours, carcinomas
and lymphomas, relative to a control
group of healthy men. This increased
erythrocyte rigidity was most pronounced
in patients with accompanying anaemia.
In this latter group, COHb, reflecting the
catabolism oferythrocyte haeme, was also
AP, cm H20/min
150 1 T
0
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FIG. 3a.-Relation between erythrocyte de-
formability (AP) and erythrocyte haeme
catabolism (COHb) for tumour-bearing
patients with anaemia (r=0-72, n=25,
P< 0-001).
No
fever
Fever No
fever
spontaneously
Fever No
fever
after
indomethacin
FIG. 4.-Erythrocyte deformability in 4
patients with Hodgkin's disease during
fever and fever-free periods. 0 With
anaemia; 0 without anaemia.
A
A
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AA A
A A
higher than in the other patients and the
reference group, and there was a strong
correlation between this variable and the
degree of erythrocyte rigidity. Since none
ofthe patients were on drugs known to be
potentialliverhaemeinducers, andtumour
infiltration of the liver was only seen in 2
A A patients in the anaemia group, there is a
strong suggestion of a relation between
A erythrocyte haemoglobin breakdown and
* * decreased deformability of the red cell.
The increased erythrocyte catabolism in
this group of patients is not followed by
reticulocytosis, and anaemia therefore
follows. It cannot be deduced from the
present investigation whether the in-
IOHb% 0.8 creased COHb levels stem from the break-
patients down of rigidified red cells in the circula-
tion or in the marrow (ie. before their
AP, cm H20/min
200 1
150
100*
50 -
0
0
0.2
0
0
AP, cm H20/min
200 1
150
100 -
50 -
o
0 0.2 0.4 0.6
FIG. 3b.-As 3a for tumour-bearing
without anaemia. No correlation.
u -
429C. E. MERCKE
release into the blood stream). As shown
in earlier studies in patients with Hodg-
kin's disease and breast carcinoma, with
and without anaemia, survival of circu-
lating red cells, as measured by labelling
the patient's own red cells with 51Cr,
were normal. The increased CO production
found in these studies was therefore attri-
butable to ineffective erythropoiesis, i.e.
increased marrow haeme catabolism
(Cavallin-Stahl et al., 1976a, b). The error
of the 51Cr-labelling method is large
however, especially in the near-normal
range. In other studies, red-cell survival
has been found to be shorter in cancer
patients, both with and without anaemia
(Hyman & Harvey, 1955; Ultman, 1958).
Apparently, decreased deformability does
not necessarily lead to increased erythro-
cyte breakdown in patients with malignant
disease, as shown in Group B in the present
study, where COHb levels were normal and
no correlation was found between COHb
values and degree of erythrocyte rigidity.
Therefore, the hypothesis of simple filtra-
tion (i.e. a purely physical process) does
not seem a sufficient explanation ofhaemo-
lysis in these disorders.
The cause of the increased red-cell
rigidity in patients with solid tumours in
the present investigation can only be
speculated on. Reticulocytes are less
deformable cells (Leblond et al., 1971)
but were not more frequent in the patient
groups than in the control group, and
cannot be ascribed to the finding. A few
other hypotheses seem valid for discussion.
It has been reported that patients with
certain malignancies have an increased
amount of echinocyte red cells in the cir-
culation (Schwarz, 1949). Such cells are
less deformable as measured with the
micropipette technique, when individual
cells can be studied (Leblond, 1973) and
can also be related to increased haeme
turnover (Mercke, 1977). Many drugs such
as anaesthetics (Van Gastel et al., 1973;
Seeman, 1972) psychotropic substances
(Seeman, 1972) and contrast media (As-
pelin, 1979) influence red-cell deform-
ability. Also endogenously produced
agents such as progesterone, increased in
concentration premenstrually (Mercke &
Lundh, 1976) and during the last trimester
of pregnancy, can alter red-cell deform-
ability (Durocher et al., 1975). In vitro
experiments by Allen & Rasmussen (1971)
showed that prostaglandin E2 could dras-
tically decrease erythrocyte deformability.
Such small amounts of PGE2 were in-
volved, that the red cell was suggested as
a primary target for PGE2 in physiological
concentrations. These experiments have
later been repeated using another method
of determining red-cell deformability. In
the present study the highest values of
AP (i.e. most deranged deformability)
were found in the 4 patients with Hodg-
kin's disease who developed fever during
the course of the investigation and were
studied 3 and 4 times respectively. Values
returned to prefever level when fever
subsided spontaneously, and reached even
lower levels after treatment with indo-
methacin, a prostaglandin-synthetase in-
hibitor. Since fever in this disease has
been attributed to secretion of prosta-
glandins by tumour tissue, a role for these
agents in red-cell deformability may be
indicated. Several very recent studies
also report increased production ofprosta-
glandins in other solid tumours, both in
experimental animals and in man (Ben-
nett et al., 1980; Droller et al., 1979;
Fiedler et al., 1979; Trevisani et al., 1980).
Even though stageing is a crude way of
deciding tumour burden and the patient
material is too small to be analysed in
detail, it seems that Group A patients,
apart from anaemia, had clinically slightly
more advanced disease. The concept of
greater PCGE2 production by a larger
tumour mass might explain the differ-
ence in red-cell haeme turnover between
Groups A and B in the present study. But
macrophages in the reticulo-endothelial
system also have a marked capacity to
produce prostaglandins, and PCGE2 in
particular (Humes et al., 1977) and this
capacity is increased when macrophages
are stimulated (Morley et al., 1979). The
difference in red-cell haeme turnover
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between Groups A and B might therefore
also reflect a difference in immunological
response, compatible with the earlier
hypothesis that hyperphagocytosis pro-
duces the anaemia in patients with malig-
nant tumours (Friedel, 1965; Hyman &
Harvey, 1955; Magarey & Baum, 1970;
Salky et al., 1967; Schacter et al., 1979).
The implications of increased rigidity
of erythrocytes in patients with malig-
nancies for the microcirculation (with
respect to perfusion, nutrition and oxy-
genation) of normal and tumour tissue
is beyond the scope of the present article.
Since it could be a factor of utmost im-
portance for the outcome ofboth the radio-
therapy and chemotherapy of tumours, it
is the subject of further exploration in
current, ongoing studies in our laboratory.
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